Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer

Inclusion Criteria: * Histologically confirmed primary cancer of the uterine cervix, uterine corpus, ovary, and fallopian tube * FIGO stage Cervical cancer: FIOG stage IA2-IIA2 Uterine cancer: FIGO stage I-III Ovarian and fallopian tubal cancer: FIGO stage I-IIIB * Patients who undergoing surgery including pelvic and/or para-aortic lymph node dissection * Patients with adequate bone marrow, renal and hepatic function: WBC \> 3,000 cells/mcl Platelets \>100,000/mcl Creatinine \<2.0 mg/dL Bilirubin \<1.5 x normal and SGOT or SGPT \<3 x normal * American Society of Anesthesiology Physical Status 0-1 * Performance status of ECOG 0-2 * Patient must be suitable candidates for surgery * Patients who have signed an approved Informed Consent Exclusion Criteria: * Patients with a history of pelvic or abdominal radiotherapy; * Patients who are pregnant * Patients with contraindications to surgery; * Patients who are unfit for Surgery: serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator); * Patient's compliance and geographic proximity that do not allow adequate follow-up. * Patients who undergo only lymph node sampling